Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Jan 2023 for Salarius Pharmaceuticals, Inc..
Filing timeline
BuySaleWilliam K. McVicar
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
William K. McVicar: trading record in brief
This profile gathers the share dealings of William K. McVicar in Salarius Pharmaceuticals, Inc., where the filings describe the role as board member. The record holds 3 filings, for trades running from 11 February 2020 to 3 January 2023.
No open-market sale appears; the market trades are 2 purchases worth €14k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant.
On 5 January 2023 came the latest disclosure, a share grant in Salarius Pharmaceuticals, Inc. The last insider purchase was made public on 7 June 2022, 1,600 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William K. McVicar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,440 shares0Common StockSEC:0001615219-23-000006:0
26,553 shares@ US$0.1883100.0% of flowCommon StockSEC:0001615219-22-000097:0
Canonical exit: 4 Sept 2022 (T+90)
2 of 2 declarations
